Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarus Lifesciences Iii, L.P Insider Profile
4 Followers
Clarus Lifesciences Iii, L.P, Ten Percent Owner at ESSA Pharma, holds 3.57M shares in ESSA Pharma (Ticker: EPIX). Most recently, Clarus Lifesciences Iii, L.P Bought 1,704,493 shares of ESSA Pharma on Aug 05, 2020 for an estimated value of 3.41M.
Clarus Lifesciences Iii, L.P ESSA Pharma (EPIX)Ten Percent Owner
ESSA Pharma (EPIX)
Ten Percent Owner
Ranked #36,158 out of 75,324 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+1.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Clarus Lifesciences Iii, L.P's holdings
Insider Roles
Ten Percent Owner
Roles that Clarus Lifesciences Iii, L.P holds in companies
Most Profitable Insider Trade
The most profitable trade made by Clarus Lifesciences Iii, L.P
Clarus Lifesciences Iii, L.P's Trading History
List of latest transactions for each holding click on a transaction to see Clarus Lifesciences Iii, L.P's performance on stock
You May Also Like
Clarus Lifesciences Iii, L.P insider profile FAQ
What is the percentage of profitable transactions made by Clarus Lifesciences Iii, L.P?
The percentage of profitable transactions made by Clarus Lifesciences Iii, L.P is 100%.
What is the average return per transaction made by Clarus Lifesciences Iii, L.P?
The average return per transaction made by Clarus Lifesciences Iii, L.P is 1.90%.
What stocks does Clarus Lifesciences Iii, L.P hold?
Clarus Lifesciences Iii, L.P holds: EPIX stocks.
What was Clarus Lifesciences Iii, L.P’s latest transaction?
Clarus Lifesciences Iii, L.P latest transaction was an Informative Buy of 3.41M.
What was Clarus Lifesciences Iii, L.P's most profitable transaction?
Clarus Lifesciences Iii, L.P’s most profitable transaction was an Informative Buy of EPIX stock on August 5, 2020. The return on the trade was 1.90%.
What is Clarus Lifesciences Iii, L.P's role in ESSA Pharma?
Clarus Lifesciences Iii, L.P's role in ESSA Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.